Aurobindo Pharma Limited (AUROPHARMA.NS) Income Statement 2004 - 2025

Aurobindo Pharma Limited

NSE:AUROPHARMA.NS

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🧬 Biotechnology

🔬 Chemicals & Advanced Materials

🔬 Clinical Trials

Location

India

Market Cap

USD 8.09 B

Share Price

USD 13.93

Avg Daily Volume

1,293,153

Change (1 day)

2.98%

Change (1 year)

-7.23%

Change (YTD)

-10.62%

Aurobindo Pharma Limited Income Statement 2015 - 2025

This table shows the Income Statement for Aurobindo Pharma Limited going from 2015 until 2025. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.